Tag: compared with a previously used GADAb RIA kit.

We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme-linked immunosorbent assay (ELISA) in subjects with childhood-onset type 1 diabetes mellitus (T1D).Serum specimens were collected from 1024 Japanese cases (426 boys and 598 girls) in 2013. The median age at diagnosis was 7 years (0-18 years).

Anti-ADA2 beta (1C8)

YF-MA11719 100 ug
EUR 363
Description: Mouse monoclonal to ADA2 beta

ADA2 ELISA Kit (Human) (OKAN06100)

OKAN06100 96 Wells
EUR 792
Description: Description of target: This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.118 ng/mL

ADA2 Chemi-Luminescent ELISA Kit (Human) (OKCD03366)

OKCD03366 96 Wells
EUR 988
Description: Description of target: Adenosine deaminase that may contribute to the degradation of extracellular adenosine, a signaling molecule that controls a variety of cellular responses. Requires elevated adenosine levels for optimal enzyme activity. Binds to cell surfaces via proteoglycans and may play a role in the regulation of cell proliferation and differentiation, independently of its enzyme activity.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.313 ng/mL

Chicken Adenosine deaminase 2, ADA2 ELISA KIT

ELI-49642c 96 Tests
EUR 928

The blood specimens were obtained at a median age of 13 years (2-22 years).Among the 628 subjects whose serum specimens were collected within 5 years after diagnosis, the rate of GADAb positivity was 47.9% using RIA and 69.4% using ELISA. The subjects were divided into four groups according to their RIA and ELISA results for GADAb as follows: Gr I (RIA+/ELISA+), Gr II (RIA+/ELISA-), Gr III (RIA-/ELISA+), and Gr IV (RIA-/ELISA-).